EnPro Industries and a bankrupt subsidiary, Garlock Sealing Technologies, have struck a deal with a plaintiffs’ lawyer to set aside $357.5 million to cover asbestos related claims, but others are expected to oppose the deal. EnPro and Garlock, a bankru…
This study is currently enrolling. Lilly will conduct a multiple-arm Phase 1/2 study examining the combination of ramucirumab with pembrolizumab in multiple tumors.
Pulmonary, University of Vermont, 226 Health Sciences Research Facility, 89 Beaumont Avenue, Burlington, VT 05405, USA. E-mail: dweiss@uvm.edu Malignant mesothelioma remains a highly deadly malignancy with poor treatment option.
Pulmonary, University of Vermont, 226 Health Sciences Research Facility, 89 Beaumont Avenue, Burlington, VT 05405, USA. E-mail: dweiss@uvm.edu Malignant mesothelioma remains a highly deadly malignancy with poor treatment option.
Last month, San Diego’s CW Network affiliate published a report about a former asbestos removal trainer who pled guilty to charges of granting training certifications to students who did not attend required asbestos training courses or passing an essen…
BIND sunk 52% since a high on November 19 to a low on January 7 as traders lost interest in the micro-cap despite compelling data and upcoming clinical trial catalyst. BIND Therapeutics is a small biotech company developing Accurins, a revolutionary ta…
Doctors in Japan have just released their findings on HUHS1015, an experimental drug they say stopped the growth of Stage IV mesothelioma tumors in laboratory mice better than some current drugs. Surviving Mesothelioma has the full story on its website.
This report provides elemental information and data relating to the clinical trials on Malignant Pleural Mesothelioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.
PLANS for the health service to recoup the cost of medical treatment from companies that exposed workers to asbestos are going out to consultation. PLANS for the health service to recoup the cost of medical treatment from companies that exposed workers…
Overexpression of activin-A and -B in malignant mesothelioma – attenuated Smad3 signaling responses and ERK activation promote cell migration and invasive growth. Activin-A and activin-B, members of the TGF- superfamily, are regulators of reproductive …
Sparkman v. A.W. Chesterton Co. 2:12-cv-2957; D.S.C. Holding: Plaintiffs have presented evidence that their decedent was exposed to at least one asbestos-containing precipitator manufactured by defendant Research-Cottrell, Inc. on a frequent, regular, …
In Wanda Beckering v. Shell Oil Company , 2014 WL 6611088, the Second District of the California Court of Appeal affirmed the granting of summary judgment in favor of defendant Shell Oil Company, finding that the plaintiff was not owed a duty of care t…
Sparkman v. A.W. Chesterton Co. 2:12-cv-02957; D.S.C. Holding: Even though defendant Foster Wheeler Energy Corp. may have manufactured one of the boilers that plaintiffs’ decedent worked on, plaintiffs have not forecasted any evidence that their decede…
Sparkman v. A.W. Chesterton Co. 2:12-cv-02957; D.S.C. Holding: Even though defendant Foster Wheeler Energy Corp. may have manufactured one of the boilers that plaintiffs’ decedent worked on, plaintiffs have not forecasted any evidence that their decede…
Sparkman v. A.W. Chesterton Co. 2:12-cv-02957; D.S.C. Holding: Even though defendant Foster Wheeler Energy Corp. may have manufactured one of the boilers that plaintiffs’ decedent worked on, plaintiffs have not forecasted any evidence that their decede…